Mr William Bielefeld > Dechert LLP > Washington DC, United States > Lawyer Profile
Dechert LLP Offices
1900 K STREET, NW
WASHINGTON DC 20006
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Mr William Bielefeld
Work Department
Financial Services and Investment Management
Position
Partner
Career
William Bielefeld advises registered funds (including open-end funds and closed-end funds) and business development companies, their investment advisers and their boards of directors/trustees on a wide range of matters relating to the development and launch of new funds, fund reorganizations, acquisitions, and mergers, regulatory and compliance matters relating to existing funds, fund governance issues and SEC examinations.
Mr. Bielefeld also represents broker-dealers and has experience with the initial organization and registration of new broker-dealers as well as ongoing registration, compliance, supervision, licensing, sales practice, advertising and suitability matters. Mr. Bielefeld also assists broker-dealers in connection with SEC and FINRA examinations and enforcement actions.
Prior to joining Dechert, Mr. Bielefeld served as an attorney-advisor in the U.S. Securities and Exchange Commission’s Office of Compliance Inspections and Examinations.
Education
- Kenyon College, B.A.
- Temple University Beasley School of Law, J.D., cum laude, Research Editor of the Temple Law Review
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation